Nasar Ata | Neurology | Best Researcher Award

Mr. Nasar Ata | Neurology | Best Researcher Award

Dr. S. M. Nasar Ata is a researcher in the Department of Neurology at Henry Ford Hospital, Detroit, USA, specializing in artificial intelligence applications in neuroscience. His work focuses on developing machine learning and soft computing–based algorithms such as CNN, ANN, SVM, and MLR for detecting and predicting brain-based disorders, including Multiple Sclerosis. He integrates metabolomics and imaging clinical data to identify biomarkers and construct predictive models for neurological and metabolic diseases. Dr. Ata collaborates with research centers such as JNMC and IBRC AMU on brain tumor prediction from MRI data and with RCDR AMU on diabetes-related model development. His research contributions include several submitted papers on metabolite prediction, deep learning in brain tumor detection, and molecular mechanisms underlying neurodegeneration and cancer. He has also authored the textbook Basics of Bio-Sciences and actively participates in scientific discussions and editorial work. With 3 published documents, 7 citations, and an h-index of 2, Dr. Ata’s growing research profile reflects his commitment to advancing data-driven neurological diagnostics through AI and biostatistical innovation.

Profiles: Scopus | Research Gate

Featured Publication

Corrigendum to “Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics data” [Multiple Sclerosis and Related Disorders, 92, 105942 (2024)]. (2024). Multiple Sclerosis and Related Disorders, 95, 106321.

Chahra Chbili | Clinical Neuroscience | Best Researcher Award

Assist. Prof. Dr. Chahra Chbili | Clinical Neuroscience | Best Researcher Award

Assist. Prof. Dr. Chahra Chbili | University of Sousse | Tunisia

Dr. Chahra Chbili is an Assistant Professor of Pharmacology at the Higher School of Health Sciences and Techniques of Sousse (ESSTSS) and a member of the Research Laboratory of Metabolic Biophysics and Applied Pharmacology (LR/12ES02) at the Faculty of Medicine Ibn El Jazzar of Sousse, Tunisia. Her academic journey spans extensive training in biological sciences, genetics, and medical biotechnology, with a Ph.D. earned with highest honors for her work on the pharmacokinetic and pharmacogenetic study of carbamazepine therapy in epileptic and bipolar patients. Dr. Chbili’s research focuses on pharmacogenetics, pharmacokinetics, and the molecular mechanisms underlying drug efficacy and toxicity. She has contributed significantly to studies exploring the genetic determinants of drug metabolism, including investigations into glutathione-S-transferases in tuberculosis patients with drug-induced hepatotoxicity. Skilled in advanced laboratory techniques such as PCR, FISH, ELISA, and HPLC-MS, she has developed expertise in integrating molecular biology with clinical pharmacology. Dr. Chbili has authored 17 scientific documents, accumulated 138 citations across 123 indexed works, and maintains an h-index of 7, reflecting her impactful contributions to pharmacological and biomedical research in Tunisia and beyond.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

Chbili, C., Mrad, S., Graiet, H., Selmi, M., Maatoug, J., Maoua, M., Abdellaoui, L., Mrizek, N., Nouira, M., Ben Fredj, M., et al. (2024). Randomized, placebo-controlled pilot study investigating the effects of Laurus nobilis tea on lipid profiles and oxidative stress biomarkers in healthy North African volunteers. The North African Journal of Food and Nutrition Research, 8(17), 86–98.

Chbili, C., Fathallah, N., Laadhari, C., Ouni, B., Saguem, S., Ben Fredj, M., Abdelghani, A., Ben Saad, H., & Ben Salem, C. (2022). Glutathione-S-transferase genetic polymorphism and risk of hepatotoxicity to antitubercular drugs in a North-African population: A case-control study. Gene, 808, 146019.

Rebai, A., Chbili, C., Ben Amor, S., Hassine, A., Ben Ammou, S., & Saguem, S. (2021). Effects of glutathione S-transferase M1 and T1 deletions on Parkinson’s disease risk among a North African population. Revue Neurologique, 177(1–2), 93–99.

Chbili, C. (2021, August 22). The effect of Origanum majorana tea on motor and non-motor symptoms in patients with idiopathic Parkinson’s disease: A randomized controlled pilot study. Journal article.

Chbili, C., Maoua, M., Selmi, M., Mrad, S., Khairi, H., Limem, K., Mrizek, N., Saguem, S., & Ben Fredj, M. (2020). Evaluation of daily Laurus nobilis tea consumption on lipid profile biomarkers in healthy volunteers. Journal of the American College of Nutrition, 39(6), 518–526.

Rebai, A., Reçber, T., Nemutlu, E., Chbili, C., Kurbanoglu, S., Kir, S., Ben Amor, S., Özkan, S. A., & Saguem, S. (2020). GC-MS based metabolic profiling of Parkinson’s disease with glutathione S-transferase M1 and T1 polymorphism in Tunisian patients. Combinatorial Chemistry and High Throughput Screening, 23(8), 785–794.

Elzbieta Paszynska | Clinical Neuroscience | Best Research Article Award

Prof. Dr. Elzbieta Paszynska | Clinical Neuroscience | Best Research Article Award

Prof. Dr. Elzbieta Paszynska | Poznan University of Medical Sciences | Poland

Professor Elzbieta Paszynska is a distinguished expert in dentistry, serving as Chair of the Department of Integrated Dentistry and Chair of Community Dentistry at Poznan University of Medical Sciences. Her academic focus includes community dentistry, adult comprehensive dental treatment, dental materials, and clinical research in oral health, particularly in patients with eating disorders. She has led numerous significant research projects, including studies on salivary biomarkers, oral health status in eating disorders, and the caries-preventive effects of hydroxyapatite toothpaste in children and adults, collaborating with multiple international institutions. Her research has contributed to over 70 scientific documents with more than 598 citations and an h-index of 13. She has published high-impact works in journals such as Scientific Reports, Frontiers in Public Health, Frontiers in Psychiatry, Nutrients, and the Journal of Dentistry. Her contributions include interdisciplinary projects integrating dentistry, ethics, and public health, and she has coordinated large-scale EU-funded projects and international collaborations. Her work has been recognized with multiple institutional and national awards for scientific excellence, teaching, and professional contributions to dentistry, as well as honors from professional dental associations. She is an active member of national boards and promotes innovation in dental education and research.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

  • Obesity and central accumulation of fat in school-age children with attention-deficit/hyperactivity disorder. (2025). Scientific Reports.

  • Miescher’s Cheilitis as a Diagnostic and Therapeutic Challenge—A Case Report. (2025). Medicina, Kaunas, Lithuania.

  • Prevalence of Toothache in Adults: A Meta-Analysis of Worldwide Studies. (2025).

  • Pain experience and behavior management: efficacy of photobiomodulation as an adjunct to local anesthesia in MIH patients—a randomized split-mouth clinical study. (2025). Frontiers in Neurology.

  • Clinical evidence of caries prevention by hydroxyapatite: An updated systematic review and meta-analysis. (2025).

Hiroshi Nagase | Neuropharmacology | Best Researcher Award

Prof. Hiroshi Nagase | Neuropharmacology | Best Researcher Award

Prof. Hiroshi Nagase | University of Tsukuba | Japan

Prof. Hiroshi Nagase is a distinguished Japanese scientist recognized for his pioneering contributions to medicinal chemistry and drug discovery. He earned his B.S., M.S., and Ph.D. degrees in Chemistry from Nagoya University, Japan, and later served as a Visiting Scientist at the University of Minnesota’s Department of Medicinal Chemistry. Dr. Nagase began his professional career at Toray Industries Inc., where he advanced from Researcher to Director in the Basic Research Laboratories. He later joined Kitasato University’s School of Pharmacy as a Professor and subsequently served as a Principal Investigator and Professor at the International Institute for Integrative Sleep Medicine (IIIS) under the World Premier International Research Center Initiative at the University of Tsukuba, where he now holds the title of Professor Emeritus. His academic and research influence extended through adjunct professorships at the University of Tokyo, the University of Nagasaki, Toyohashi Polytechnic College, and Nagoya University. Dr. Nagase has authored 39 scientific documents, which have collectively garnered 279 citations from 189 sources, reflecting his substantial impact on the field. With an h-index of 10, his research continues to inspire advancements in medicinal chemistry, neuropharmacology, and therapeutic innovation.

Profiles: Scopus | Research Gate

Featured Publication

Nagase, H. (2025). Development of novel bioactive alkaloids based on specific reactions of the 4,5-epoxymorphinan framework. Synlett.

[Authors not listed]. (2025). Delta opioid receptor agonists activate PI3K–mTORC1 signaling in parvalbumin-positive interneurons in mouse infralimbic prefrontal cortex to exert acute antidepressant-like effects. Molecular Psychiatry.

Priyadharshini Veeralakshmanan | Clinical Neuroscience | Best Researcher Award

Ms. Priyadharshini Veeralakshmanan | Clinical Neuroscience | Best Researcher Award

Ms. Priyadharshini Veeralakshmanan | Amrita Vishwa Vidyapeetham | India

Ms. Priyadharshini Veeralakshmanan is a dedicated PhD scholar at Amrita Vishwa Vidyapeetham, specializing in Medical Oncology with a focus on Breast Cancer Immunology and the immunosuppressive tumour microenvironment (TME), particularly in Triple-Negative Breast Cancer (TNBC). Her doctoral research involves a Phase 2/3 open-label pilot clinical trial to evaluate neoadjuvant metronomic chemotherapy for modulating the TME and enhancing chemo- and immunotherapy responses, quantifying immunosuppressive cells and tumour-infiltrating lymphocytes from blood and tumour tissue. She holds an M.Sc. in Physician Assistant (Medical Oncology) and a B.Sc. in Physician Assistant (General Medicine), with extensive clinical training in oncology, hematology, surgical oncology, radiation oncology, and palliative care. Priyadharshini has strong expertise in flow cytometry, cell culture, in vitro drug testing, cytotoxicity assays, systematic reviews, meta-analysis, and clinical trial design, using advanced analytical tools such as FlowJo, SPSS, and GraphPad Prism. She has authored several publications, with an h-index of 3, over 7 documents, and more than 50 citations. A member of ESMO, ASCO, and I-OSI, she is committed to advancing cancer research, translating innovative findings into clinical practice to improve patient outcomes globally.

Profiles: Orcid | Linked In

Featured publications

Veeralakshmanan, P., Jose, W. M., Udayakumaran, S., Bindhu, M. R., Dutta, D., Rajesh, K., Kavalagunta, S., Bhaskaran, R., Haridas, N. K., Rakesh, M. P., et al. (2025). Multimodal management and outcome of pediatric and adolescent malignant central nervous system tumors: A single‐center retrospective study. Malignancy Spectrum.

Surendran, H. P., Sah, S. K., Veeralakshmanan, P., Nair, P., Ashok, H. P., Unnikrishnan, M. K., Kalavagunta, S., Sasidharan, A., Chandran, D., Poornachary, N. M., et al. (2025). Efficacy of hippocampal avoidance whole brain radiotherapy to preserve the cognitive functions among brain metastasis patients: Systematic review and meta-analysis. Neurology India, 73(5), 715–725.

Irene Litvan | Clinical Neuroscience | Best Researcher Award

Dr. Irene Litvan | Clinical Neuroscience | Best Researcher Award

Dr. Irene Litvan | University of California San Diego | United States

Dr. Irene Litvan, MD, is the Tasch Endowed Professor of Neurology and Director of the Parkinson and Other Movement Disorders Center at the University of California, San Diego. She is internationally recognized for her pioneering work in movement disorders, particularly Parkinson’s disease and related neurodegenerative conditions. As a leading clinician-scientist, she has directed major multicenter and international initiatives to develop clinical and neuropathologic diagnostic criteria, identify disease biomarkers, and advance therapeutic interventions. Her extensive research spans epidemiologic, genetic, and clinico-pathologic correlation studies that have significantly deepened the understanding of movement disorders. Dr. Litvan’s scholarly impact is reflected in 6 published documents, 10 citations, and an h-index of 1. Throughout her distinguished career, she has received consistent funding support from national and international agencies, industry collaborations, and philanthropic organizations. Beyond her research, she has served as a dedicated mentor, shaping the next generation of neurologists and neuroscientists. Dr. Litvan also leads the UC San Diego Parkinson and Other Movement Disorders Center, fostering clinical excellence and research innovation aimed at improving diagnosis, management, and quality of life for individuals with Parkinson’s disease and other movement-related neurological disorders.

Featured Publications

Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., et al. (2015). MDS clinical diagnostic criteria for Parkinson’s disease. Movement Disorders, 30(12), 1591–1601.

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., Feldman, H., et al. (2005). Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology, 65(12), 1863–1872.

Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A frontal assessment battery at bedside. Neurology, 55(11), 1621–1626.

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., et al. (2007). Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorders, 22(12), 1689–1707.

Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., et al. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders, 27(3), 349–356.

Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., et al. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS–SPSP international workshop. Neurology, 47(1), 1–9.

Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., et al. (2017). Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria. Movement Disorders, 32(6), 853–864.

Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Mrs. Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Mrs. Claudia Pauciulo | Borghesiana Veterinary Clinic | Italy

Mrs. Claudia Pauciulo is the Head of the Neurology and Neurosurgery Department at Borghesiana Veterinary Clinic in Rome, Italy, and a certified veterinary neurologist completing her ECVN Residency. She holds a Master’s Degree in Diagnostic Imaging and a GP Certificate in Neurology, combining strong academic training with extensive clinical experience in advanced diagnostics (MRI, CT), neurosurgery, and case management. Her research focuses on feline and canine hyperesthesia syndromes, central nervous system lymphoma, intervertebral disc disease, and peripheral neuropathies. Dr. Pauciulo has published as both first author and coauthor in high-impact, peer-reviewed journals, including the Journal of Veterinary Internal Medicine, Journal of the American Veterinary Medical Association, Veterinary Record Case Reports, Journal of Small Animal Practice, and Veterinary Sciences (MDPI). She maintains an active citation record with growing visibility in Scopus- and SCI-indexed publications. Her current h-index is 2, with a total of 10 citations across multiple publications. Through her collaborative research with leading ECVN diplomates and contributions to international neurology congresses, Dr. Pauciulo continues to advance veterinary neuroscience, integrating clinical excellence with innovative research to improve evidence-based therapeutic strategies for neurological disorders in companion animals.

Profiles: Orcid | Linked In

Featured Publication

Pauciulo, C., & Gallucci, A. (2025, September 25). Long‐term outcome of presumptive idiopathic hyperesthesia syndrome in a dog treated with fluoxetine. Veterinary Record Case Reports.

Kailas Chavan | Neuropharmacology | Best Researcher Award

Mr. Kailas Chavan | Neuropharmacology | Best Researcher Award

Mr. Kailas Chavan | Indian Institute of Technology Jodhpur | India

Kailas Arjun Chavan is a doctoral researcher at the Indian Institute of Technology Jodhpur, specializing in organic chemistry under the mentorship of Dr. Rohan D. Erande. His Ph.D. research focuses on the isolation and synthesis of bioactive scaffolds, including bis-indolyl compounds, flavonoids, and constituents of Pterocarpus marsupium, alongside the development of nickel-catalyzed direct conversion of alcohols to trans-cinnamonitriles. He completed his M.Sc. in Organic Chemistry at Dr. Babasaheb Ambedkar Marathwada University, where he investigated Cs₂CO₃-catalyzed reactions for the efficient synthesis of dihydroquinazolin-4(1H)-one. Kailas has contributed to the scientific community through 6 publications, amassing 94 citations. His research interests bridge synthetic methodology with bioactive compound exploration, aiming to advance medicinal chemistry and sustainable synthesis. Kailas’s work reflects a strong commitment to chemical innovation, positioning him as a promising emerging scientist in his field.

Profiles: Scopus | Google Scholar | Research Gate | Linked In

Featured Publications

Chavan, K. A., Shukla, M., Chauhan, A. N. S., Maji, S., Mali, G., Bhattacharyya, S., … (2022). Effective synthesis and biological evaluation of natural and designed bis(indolyl)methanes via taurine-catalyzed green approach. ACS Omega, 7(12), 10438–10446.

Mali, G., Maji, S., Chavan, K. A., Shukla, M., Kumar, M., Bhattacharyya, S., … (2022). Effective synthesis and biological evaluation of functionalized 2,3-dihydrofuro[3,2-c]coumarins via an imidazole-catalyzed green multicomponent approach. ACS Omega, 7(40), 36028–36036.

Shivam, S., Chavan, K. A., Chauhan, A. N. S., Erande, R. D. (2023). Recent advances in [3+2]-cycloaddition-enabled cascade reactions: Application to synthesize complex organic frameworks. Synlett, 34(07), 709–728.

Mali, G., Chauhan, A. N. S., Chavan, K. A., Erande, R. D. (2021). Development and applications of double Diels‐Alder reaction in organic synthesis. Asian Journal of Organic Chemistry, 10(11), 2848–2868.

Sharma, V., Chavan, K. A., Mali, G., Sarkar, D., Lama, P., Majumder, M., … (2023). A catecholaldimine-based NiII-complex as an effective catalyst for the direct conversion of alcohols to trans-cinnamonitriles and aldehydes. The Journal of Organic Chemistry, 88(11), 7448–7453.

Chavan, K. A., Sonawane, O. A., Erande, R. D. (2025). Novel metabolites from Pterocarpus marsupium: Structural characterization and biological relevance. Tetrahedron Letters, 155820.

Sang Yun Seok | Clinical Neuroscience | Best Researcher Award

Prof. Sang Yun Seok | Clinical Neuroscience | Best Researcher Award 

Prof. Sang Yun Seok,  Busan Bumin Hospital, South Korea.

Dr. Sangyun Seok is a highly accomplished spine surgeon and medical academic whose career spans clinical excellence, international training, and impactful research. He completed his medical education and master’s degree at Dong-A University, followed by intensive clinical training and military service. His professional career includes esteemed positions at Asan Medical Center, Eulji Medical Center, and fellowships in the USA, UK, and Japan, culminating in his current role at Busan Bumin Hospital. Dr. Seok’s primary research focus lies in cervical spine surgery and minimally invasive techniques, with numerous publications in top-tier international journals. His clinical expertise, global collaborations, and forward-looking vision continue to influence the field of spinal surgery.

Profile

Orcid

Strengths for the Award

  • Focused Research Expertise: His specialized focus on cervical spine surgery and minimally invasive spine techniques addresses high-impact areas in clinical orthopedics and neurosurgery, benefiting both patients and the broader medical community.

  • Robust Publication Record: Dr. Seok has published in top-tier journals including Neurospine, Clinical Spine Surgery, Global Spine Journal, and J Neurosurg Spine, contributing to both practical advancements and theoretical insights in spine surgery.

⚠️ Areas for Improvement

  • Grant Acquisition and Leadership Roles: There is limited information on leading major funded research projects or international consortia. Taking lead investigator roles in large-scale studies or securing competitive research grants would significantly bolster his profile.

  • Innovation and Patents: Future work could include intellectual property contributions, such as device development, patents, or clinical guidelines, to complement his strong publication base.

🎓 Early Academic Pursuits

Dr. Sangyun Seok embarked on his medical journey at Dong-A University College of Medicine in Busan, Korea, where he earned his Bachelor’s degree in Medicine between 2006 and 2012. His passion for advancing medical knowledge led him to pursue a Master’s degree in Medicine from the same institution during 2014–2016, laying a solid academic foundation in clinical and surgical sciences. His formative years were marked by diligence, academic excellence, and a clear focus on the musculoskeletal and spinal health domains.

🏥 Professional Endeavors

Following his academic achievements, Dr. Seok underwent rigorous clinical training at Dong-A University Hospital from 2012 to 2017, where he honed his clinical and surgical skills. After serving his nation through the Korean military service from 2017 to 2020, he returned to the healthcare field with renewed dedication. His professional career advanced rapidly with appointments at Asan Medical Center in Seoul, followed by a tenure as Assistant Professor at Eulji Medical Center in Daejeon (2021–2025). Dr. Seok’s career reflects a blend of clinical service, academic leadership, and global medical engagement, including fellowships in the USA, UK, and Japan. As of 2025, he continues his professional journey at Busan Bumin Hospital, further strengthening Korea’s spine surgery community.

🔬 Contributions and Research Focus

Dr. Seok’s research contributions are deeply rooted in the field of spine surgery, with a sharp focus on the cervical spine and minimally invasive surgical techniques. His academic output reflects a commitment to improving surgical outcomes and patient recovery. Among his impactful works are studies on vertebral osteotomy for cervical myelopathy, postoperative delirium after knee arthroplasty, and minimally invasive approaches in complex cervical procedures. His research has been published in reputable journals such as Neurospine, Clinical Spine Surgery, Global Spine Journal, and Journal of Neurosurgery: Spine, underlining his authority and innovation in spine surgery.

Publication


Title: Analysis of Early Post-Radiation Surgical Management of Metastatic Spinal Tumors
Author: SANGYUN SEOK, Jae Hwan Cho, Hyung Rae Lee, Jae Woo Park, Jin Hoon Park, Dong-Ho Lee, Chang Ju Hwang, Sehan Park
Year: 2025


Title: Mechanical Stability and Clinical Outcomes Following Posterior Cervical Fusion Surgery Using C3-6 Lateral Mass Screw Fixation: En Bloc Versus Regional Screw Fixation
Author: Dong-Ho Lee, SANGYUN SEOK, Woon Sang Lee, Hyung Rae Lee, Sehan Park, Chang Ju Hwang, Jae Hwan Cho
Year: 2025

🏁 Conclusion

Dr. Sangyun Seok is highly deserving of the Best Researcher Award. His trajectory is marked by deep scientific curiosity, technical mastery, and global vision. His work has already contributed meaningfully to advancing spinal surgery, and with continued research leadership, he is poised to make even greater contributions in the years ahead. Recognizing him with this award would not only honor his current accomplishments but also inspire future breakthroughs in spine medicine and academic surgery.

Kumud Bala | Molecular and Cellular Neuroscience | Excellence in Research Award

Prof. Kumud Bala | Molecular and Cellular Neuroscience | Excellence in Research Award

Prof. Kumud Bala, Amity University, India.

Prof. Kumud Bala is a seasoned academic and researcher in the fields of biotechnology and immunology, with a rich educational background that includes a Ph.D. from Patna University in collaboration with AIIMS. She has over 25 years of teaching and research experience, primarily at Amity University, Noida, where she currently holds the position of Professor at the Amity Institute of Biotechnology. Her professional journey has been marked by consistent progression, interdisciplinary teaching, and impactful research. She has contributed significantly to biotechnology education through curriculum development, student mentorship, and translational research projects that align closely with real-world biomedical challenges.

Profile

Google Scholar
Orcid
Scopus

Early Academic Pursuits

Prof. Kumud Bala’s academic journey began with a strong foundation in the life sciences at Patna University, where she earned her B.Sc. in Zoology in 1992, followed by an M.Sc. in Immunology in 1995. Her passion for understanding the intricate mechanisms of biological systems led her to pursue a Ph.D. in Biotechnology, a collaborative program between Patna University and AIIMS, which she successfully completed in 2003. This solid educational background laid the groundwork for her long-standing academic and research career in the field of biotechnology and immunology.

Professional Endeavors in Higher Education

Prof. Bala has cultivated a distinguished teaching and research career over nearly three decades, beginning in 1996 as a Lecturer at St. Columba’s College, Hazaribag, where she contributed for over a decade. She later joined Amity University, Noida, where she steadily rose through the academic ranks—from Senior Lecturer at the Amity Institute of Advanced Training and Research to Expert Faculty at the Amity Institute of Pharmacy, and eventually to Assistant Professor III in 2009. Her dedication and academic excellence led to her promotion as Associate Professor in 2013, and she currently serves as a Professor at the Amity Institute of Biotechnology since 2019. Her professional journey is a testament to her unwavering commitment to knowledge dissemination and academic leadership.

Contributions and Research Focus

Prof. Bala’s research primarily revolves around biotechnology and immunology, with deep insights into molecular mechanisms of disease, therapeutic interventions, and diagnostic innovations. Her work often bridges interdisciplinary domains, particularly in translational research aimed at addressing immunological disorders and enhancing biotechnological applications in healthcare. Through her roles in academia, she has significantly contributed to shaping curricula, mentoring research scholars, and advancing scientific inquiry in life sciences. Her scholarly output reflects a commitment to both foundational and applied research in biomedical biotechnology.

Accolades and Recognition

While explicit accolades are not detailed in the record, Prof. Bala’s rise through academic ranks and continued tenure at a leading private university in India—Amity University—indicates a high level of institutional recognition. Her roles have involved strategic responsibilities in curriculum development, research coordination, and interdisciplinary teaching, underscoring her reputation as a trusted educator and researcher. The trust placed in her for long-term roles across diverse faculties also reflects professional respect and recognition among peers.

Impact and Influence on Biotechnology Education

Prof. Bala has profoundly influenced biotechnology education in India through her dynamic teaching methodologies and innovative research projects. Her involvement in training students from pharmacy, advanced research, and biotechnology backgrounds positions her at the center of a multidisciplinary educational landscape. Her ability to integrate academic theory with practical applications has shaped the perspectives of numerous undergraduates, postgraduates, and research aspirants, many of whom have pursued impactful careers in biomedical sciences and allied fields.

Legacy in Research and Mentorship

A hallmark of Prof. Bala’s career is her enduring legacy as a mentor and scientific guide. Her role in mentoring early-career scientists and guiding them through complex research problems stands as one of her most valuable contributions to academia. Her collaborative ethos, combined with her scientific rigor, has fostered a culture of excellence and innovation. Her efforts have ensured that research in biotechnology not only thrives in academic settings but also responds to real-world health challenges.

Future Vision and Continuing Contributions

Looking ahead, Prof. Kumud Bala continues to be an influential voice in biotechnology and immunology, actively participating in the academic and scientific community at Amity University and beyond. With the growing importance of biotechnology in global healthcare, she is uniquely positioned to lead future projects focused on interdisciplinary research, biomedical innovation, and policy-oriented science education. Her unwavering commitment to scientific growth and mentorship guarantees that her impact will be felt for generations to come.

Publication

1. Morphological examination of ear: a study of an Indian population – PK Chattopadhyay, S Bhatia – 2009


2. Herbal contraceptive: an overview – K Bala, M Arya, DP Katare – 2014


3. Adverse effect of combined oral contraceptive pills – A Shukla, R Jamwal, K Bala – 2017


4. Dealing Wildlife Offences in India: Role of the Hair as Physical Evidence – VT V Sahajpal, SP Goyal, Kumudbala Singh – 2009


5. In vitro antioxidant activity of defatted seed extracts of Ocimum sanctum on rat PC-12 cells and its inhibitory efficacy with receptors of oral squamous cell carcinoma – Y Sharma, M Bharadwaj, N Srivastava, A Kaur, M Kumar, M Agarwal, … – 2020


6. In-vitro antiproliferative efficacy of Abrus precatorius seed extracts on cervical carcinoma – A Kaur, Y Sharma, A Kumar, MP Ghosh, K Bala – 2022


7. Antioxidant activity of polyphenolic flavonoid of stem of Nicotiana tabacum – Y Sharma, A Nagar, NS Srivastava, K Bala – 2017


8. Comparative study of different parts of fruits of Musa Sp. on the basis of their antioxidant activity – Y Sharma, A Chauhan, K Bala, A Nagar – 2016


9. Preclinical assessment of stem of Nicotiana tabacum on excision wound model – Y Sharma, A Kaur, R Bhardwaj, N Srivastava, M Lal, S Madan, K Bala – 2021


10. Nosocomial infection by non-fermenting gram negative bacilli in tertiary care hospital: Screening and cure – R Wadhwa, Y Sharma, RP Upadhyay, K Bala – 2016

 

Conclusion

Prof. Kumud Bala’s career reflects a strong blend of academic rigor, research excellence, and educational leadership. Through her deep involvement in immunology and biotechnology, she has shaped the academic paths of numerous students and contributed to advancing science education in India. Her enduring commitment to scientific inquiry, mentorship, and innovation positions her as a respected figure in her field. Moving forward, her work promises to continue influencing both academic advancement and practical healthcare solutions, reinforcing her role as a pivotal contributor to the growth of life sciences in higher education.